Dna damage checkpoints initially were defined as regulatory pathways that control the ability of cells to arrest the cell cycle in response to dna damage, allowing time for repair. Resistance to therapy in brca2 mutant cells due to loss of. Mrc genome damage and stability centre, school of life sciences, university of sussex, falmer, brighton, bn1 9rq 2. Modeling chemotherapyinduced stress to identify rational. Signatureguided approaches for targeting dna damage response. At the heart of the ddr are the related signaling kinases atm, atr, and dnapk, which regulate dna repair and associated events such as cell cycle checkpoints, chromatin remodeling, transcription, and. These include events that lead to cellcycle arrest, regulation of dna replication, and the repair or bypass of dna damage. Use of poly adpribose polymerase parp inhibitors in. This industryfocused summit will equip you with the tools to optimize parp inhibitors for expanded indications. Evaluating the moleculebased prediction of clinical drug. A hormonedna repair circuit governs the response to. Translational and basic science opportunities in palliative. Therapeutic opportunities within the dna damage response nature. Table 1 pathways involved in the dna damage response and the number of genes associated with each pathway.
Targeted therapy based on inhibiting the dna damage response ddr in cancers offers the potential for a greater therapeutic window by tailoring treatment to patients with tumors lacking specific ddr functions. Deficiencies in these responses, particularly in repair of different damaged dna are of tremendous importance in the etiology of human cancers and at the same time offer great opportunities for designing targeted therapeutic strategies. Polyadpribosepolymerase 1 parp is a nuclear enzyme involved in dna repair. Targeting cellular proteins like parps, which cooperate and complement molecular defects of the ddr process, induces a specific lethality in ddr defective cancer cells and. In cancer, the critical balance between the loss of genomic stability in malignant cells and the ddr provides exciting therapeutic opportunities. Excess iron is tightly associated with tumorigenesis in multiple human cancer types through a variety of mechanisms including catalyzing the formation of mutagenic hydroxyl radicals, regulating dna replication, repair and cell cycle progression, affecting signal transduction in cancer cells, and acting as an essential nutrient for proliferating tumor cells. Targeting the dna damage response in cancer sciencedirect. Longer repeat expansions are associated with genetic anticipation ie, earlier. Inherited diseases caused by unstable repeated dna sequences are rare, but together represent a substantial cause of morbidity. Cdk5 links with dna damage response and cancer molecular.
Signatureguided approaches for targeting dna damage. Although recent data indicate that h2b monoubiquitination is strongly connected with tumor progression and regulation, the implications of this modification in lung adenocarcinoma are relatively unknown. Emerging cancer therapeutic opportunities target dnarepair. Role of nbs1 in dna damage response and its relationship. There are likely many additional opportunities to exploit the dna damage response for the benefit of cancer patients, given that genome instability is a hallmark of cancer and there is intense. This chapter outlines the discovery of the parp family and the rationale for the development of parp inhibitors as a novel class of anticancer agents, with a brief evaluation of the preclinical evidence for chemopotentiation, radiopotentiation, and also single agent activity in homologous recombination. Dna repair in the trinucleotide repeat disorders the. A better understanding of the cellular response to dna damage will not only inform our knowledge of cancer development but also help to refine the classification as well as the treatment of the disease. Translational and basic science opportunities in palliative care and radiation oncology radiation therapy is commonly used in the metastatic setting to palliate pain, neurological deficits, bleeding and other complications of metastatic disease, allowing patients to live longer and have better quality of life. Restoration of cisplatin resistance is independent of hr but correlates with restored cell cycle progression, reduced chromosomal aberrations, and enhanced dna damage tolerance. The inhibition of eight molecular targets within the dna damage response pathway atm, atr, dnapk, chk1, chk2, p53, p21, and chk12 was simulated. The dna damage response ddr is essential for maintaining the genomic integrity of the cell, and its disruption is one of the hallmarks of cancer. Targeted therapy based on inhibiting the dna damage response. The outcome is quantified as log 10 fold change of cell number after 3 days of the drug.
However, recent work has demonstrated that the ddr network extends far beyond the atrchk1 and atmchk2 axes. The ddr detects aberrant dna and chromosomal structures and elicits a multifaceted response network to coordinate multiple cellular processes, including regulation of the cell cycle, dna repair, replication and, under certain circumstances, the triggering of programmed cell death. The dnadamage response in human biology and disease. Jan 18, 2012 genomic instability is one of the most pervasive characteristics of tumour cells and is probably the combined effect of dna damage, tumourspecific dna repair defects, and a failure to stop or. These lesions can block genome replication and transcription, and if they are not repaired or are repaired incorrectly, they lead to mutations or widerscale genome aberrations that threaten cell or organism viability. Genomic instability is a typical cancer hallmark due to dna damage by genetic mutations, reactive oxygen and. The cell cycle comprises the sequence of coordinated events that take place in a cell, known as cell cycle phases, that enable the cell to faithfully duplicate its. As an atypical member of cyclin dependent kinase family, cyclin dependent kinase 5 cdk5 is considered as a neuronspecific kinase in the past decade due to the abundant existence of its activator p35 in postmitotic neurons. Therapeutic opportunities within the dna damage response core. Aside from dnadamaging chemotherapeutic agents, nfkb inhibition in breast cancer cells can. These insults activate the p53 and p16 ink4a tumor suppressor pathways and potentially other pathways that initiate a senescence response. Chromosomal instability cin is the result of ongoing changes in the number aneuploidy and structure of chromosomes.
Parp and novel dna damage response ddr inhibitors are showing great potential in broader tumor indications as they advance through the clinic. Inhibiting the dna damage response as a therapeutic. One basic process that may contribute to agerelated dysfunction and chronic sterile inflammation is cellular senescence figure figure2. Emerging cancer therapeutic opportunities target dna. Senescencecausing inducers include repeated cell division and strong mitogenic signals, telomere shortening, dna damage and mutations, protein aggregation, and increased ros 46, 56 60. Genomic instability is a typical cancer hallmark due to dna damage by. Reviews the dna damage response in human biology and disease stephen p. Translational and basic science opportunities in palliative care and radiation oncology radiation therapy is commonly used in the metastatic setting to palliate pain, neurological deficits, bleeding and other complications of metastatic disease, allowing patients to. Therapeutic opportunities within the dna damage response. The ongoing molecular characterization of the dna damage response ddr and pathway crosstalk is invaluable in helping scientists learn how to modulate dna repair. Dna damage elicits various response pathways, which aim to repair the damage or eliminate cells if the damage is beyond repair.
Recent advances in genomewide methylation methods have provided the means to identify differentially methylated genes, methylation signatures, and potential biomarkers. Targeting oxidatively induced dna damage response in. In general terms, the ddr can be divided into a series of distinct, but functionally interwoven, pathways, which are defined largely by the type of dna lesion they process fig. Despite a longstanding understanding that many endogenous and exogenous agents can damage dna, knowledge of how dna repairs itself was largely an academic pursuit until the last two decades. Targeting cellular proteins like parps, which cooperate and complement molecular defects of the ddr process, induces a specific lethality in ddr defective cancer cells and represents an anticancer strategy. While parp inhibitors have led the way, and are increasingly being recognized as a targeted therapeutic approach for patients with brca mutations and. The dna damage response ddr is a crucial signalingtransduction. Defects of dna damage response are considered as a hallmark of human cancer. Traip regulates histone h2b monoubiquitination in dna. The dna damage response ddr network is a system of cellular pathways that monitor and repair dna damage in an effort to maintain genomic integrity throughout the cell cycle. Regardless of the overall prooncogenic function of cin, its onset is. Histone h2b monoubiquitination has been shown to play critical roles in diverse cellular processes including dna damage response. Elucidating the complexity of ddr network will contribute meaningfully and decisively to our understanding of cancer biology and cancer treatment. Cin is induced by chromosome missegregation in mitosis and leads to karyotypic diversity within the cancer cell population, thereby adding to intratumor heterogeneity.
A proficient ddr has been shown to be a primary cause for cellular resistance to the very many dna damaging drugs, and ir, that are widely. Crisprcas9based dna damage response screens reveal gene. Dna repair in the trinucleotide repeat disorders the lancet. Reviews the dnadamage response in human biology and disease stephen p. Here we performed a genomewide shrna screen and found that loss of the nucleosome remodeling factor chd4 confers cisplatin resistance. Longer repeat expansions are associated with genetic anticipation ie, earlier disease onset in. May 17, 20 the dna damage response ddr, consisting of an orchestrated network of proteins effecting repair and signalling to cell cycle arrest, to allow time to repair, is essential for cell viability and to prevent dna damage being passed on to daughter cells. Jul, 2017 normal longterm hscs are in quiescent state within the bonemarrow niche, but in response to stressinducing stimuli such as viral infections, cytopenias, cytokines e. Dna damage response inhibition is an anticancer platform which could. The role and clinical significance of dna damage response and. The dna damage response ddr is a collective term for the plethora of different intra and intercellular signaling events and enzyme activities that result from the induction and detection of dna damage. U nexpectedly, clinical observations suggest that steroid hormones might modulate the response to dna damage in hormoneresponsive cancers. To help identify new therapeutic opportunities within the ddr. Hypoxia and cancer biological implications and therapeutic.
Interference with dna repair has emerged as an important approach in. Recent studies show that cdk5 participates in a series of biological and pathological processes in nonneuronal cells, and is generally. The recent approval of olaparib lynparza, the poly adpribose polymerase parp. In addition, these somatic defects provide opportunities to exploit a reliance on remaining repair pathways for survival, a process which has been termed synthetic. Dna damaging agents have a central role in nonsurgical cancer treatment. Therapeutic opportunities within the dna damage response laurence h. Alterations in dna repair promote tumor development, but the impact on tumor progression is poorly understood. Trinucleotide repeat disorders are severe, usually lifeshortening, neurological disorders caused by nucleotide expansions, and most have no diseasemodifying treatments. Dna doublestrand breaks dsbs a critical feature of the eukaryotic cell is its ability to maintain genome stability across generations, attributed, in part, to the sophisticated and precisely. Even within a specific category of dna damage, the machinery utilized for repair varies due to the chemistry of the damage, the damage context, differential expression or posttranslational modification of repair factors, the chromatin state and the cell cycle. An elevated dnarepair capacity in tumor cells leads to drug or radiation resistance and severely limits the efficacy of these agents. The dna damage response ddr network includes multiple cellular pathways that sense, signal and repair dna lesions, which are critically important for cell survival and genome maintenance. Although these processes drive genomic instability and ultimately the disease process, they also provide therapeutic opportunities. Kinase targeting combined with dnadamaging cancer therapy catalyzes mitotic.
These targets include the protein kinases involved in cell cycle dna checkpoint for dna damage andor replicative stress eg chek1, wee1, and individual. Use of poly adpribose polymerase parp inhibitors in cancer. Hif triggers the expression of genes whose products induce angiogenesis, decrease oxygen consumption, switch metabolism to glycolysis, maintain a stem cell phenotype and select for more invasive and metastatic cells. Moleculebased prediction of drug response is one major task of precision oncology. Improved outcome through targeted interventions faces the scarce selectivity of the therapies and the development of resistance to them that compromise the therapeutic effects. Dnadamaging agents have a central role in nonsurgical cancer treatment. Request pdf therapeutic opportunities within the dna damage response the dna damage response ddr is essential for maintaining the genomic integrity of the cell, and its disruption is one of. Interference with dna repair has emerged as an important approach in combination therapy against. In addition, many therapies are scarcely selective for cancer cells and damage healthy cells thus compromising the therapeutic effect 5.
The dna damage response ddr is a signaling cascade of proteins that interact upstream with damaged dna and downstream with regulators of cell cycle progression and cell survival. Pearl is head of the school of life sciences at the university of sussex, brighton, uk, and professor of structural biology in the genome damage and stability centre. Genomic instability is one of the most pervasive characteristics of tumour cells and is probably the combined effect of dna damage, tumourspecific dna repair defects, and a failure to stop or. Hypoxia inducible factor 1 hif1 is a master regulator of the transcriptional response to oxygen deprivation. Jul 24, 2018 the inhibition of eight molecular targets within the dna damage response pathway atm, atr, dna pk, chk1, chk2, p53, p21, and chk12 was simulated. Findings show that androgen receptor ar activity is induced by dna damage and promotes expression and activation of a. Collectively, these mechanisms are known as the dna damage response ddr. More recently, protein components of the ddr systems have been identified.
Classically, defects in the ddr have been exploited therapeutically in the treatment of cancer with radiation therapies or genotoxic chemotherapies. Although we refer to this as a pathway, it is more accurately described as a networkof interacting pathways that together execute the response. Recently, largescale cancer genomic studies, such as the cancer genome atlas tcga, provide the opportunity to evaluate the predictive utility of molecular data for clinical drug responses in multiple cancer types. Role of nbs1 in dna damage response and its relationship with cancer development nijmegen breakage syndrome nbs is a recessive genetic disorder characterized by an elevated sensitivity to ionizing radiation, chromosome instability, and a high frequency of malignancies phenotypes similar to those of ataxiatelangiectasia at. The complexity of dna damage response ddr molecular networks their role in preventing the tumorigenic process therapeutic opportunities opportunities and challenges for combination therapy summary this slide is the intellectual property of the authorpresenter. Here, discovery of a biochemical circuit linking hormone signaling to dna repair and therapeutic resistance is reported. The effect of chemotherapies is simulated as monotherapy or in combination bars and shown on the x axis. As research advances, we continue to expand our knowledge and understanding of novel targets in dna damage response as potential therapeutic options in oncology. Request pdf therapeutic opportunities within the dna damage response the dna damage response ddr is essential for maintaining the genomic integrity of. Cellular senescence and the senescent secretory phenotype. An elevated dna repair capacity in tumor cells leads to drug or radiation resistance and severely limits the efficacy of these agents. In mammalian cells, the dna damage response ddr prevents the replication and propagation of dna errors to the next generation, thus maintaining genomic stability.
Cancer is a death cause in economically developed countries that results growing also in developing countries. General organization of the dna damage response pathway the dna damage response pathway is a signal transduction pathway consisting of sensors, transducers and effectors fig. Molecular targets and clinical applications, second edition provides a comprehensive and timely reference that focuses on the translational and clinical use of dna repair as a target area for the development of diagnostic biomarkers and the enhancement of cancer treatment experts on dna repair proteins from all areas of cancer. Cancer associated defects in the dna damage response. Dna damage response pathways and cancer clinical gate. The dna damage response pathway in normal hematopoiesis and. Aberrant dna methylation is an epigenetic hallmark of melanoma, known to play important roles in melanoma formation and progression. Targeting the dna damage response for anticancer therapy. The dna damage response pathway in normal hematopoiesis. Jci cellular senescence and the senescent secretory. Regardless of the overall prooncogenic function of cin, its onset is typically detrimental for cell fitness. The dna damage response ddr, consisting of an orchestrated network of proteins effecting repair and signalling to cell cycle arrest, to allow time to repair, is essential for cell viability and to prevent dna damage being passed on to daughter cells. Targeting oxidatively induced dna damage response in cancer. Over the past decade a complex role for dna damage response ddr in tumorigenesis has emerged.
Sarscov2 transmission sarscov2 is highly infectious. Dna damage response ddr defects imply genomic instability and favor tumor progression but make the cells vulnerable to the pharmacological inhibition of the dna repairing enzymes. Inhibiting the dna damage response as a therapeutic manoeuvre. There is now strong evidence that cellular senescence is. Traip regulates histone h2b monoubiquitination in dna damage. A proficient ddr has been shown to be a primary cause for cellular resistance to the very many dna damaging drugs, and ir, that are widely used as standardofcare across multiple cancer types. Cellular senescence refers to the essentially irreversible growth arrest that occurs when cells experience potentially oncogenic insults 3338. The balance between dna damage and repair determines the final therapeutic consequences. The deoxyribonucleic acid dna damage response ddr pathway is a surveillance network, whereby lesions are eliminated from dna to ensure genomic integrity. Cancerassociated defects in the dna damage response. This complexity is particularly evident for dna alkylation damage.
1327 1414 296 1084 1165 1420 187 804 1347 1157 847 1041 41 528 540 226 1499 1131 1276 671 1330 589 1378 1560 520 1263 684 120 83 150 823